D

Delcath Systems
D

DCTH

10.480
USD
0.73
(7.49%)
Market Closed
Volume
7,326
EPS
-1
Div Yield
-
P/E
-9
Market Cap
335,085,256
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    C
    CRMD
    -0.660
    (-6.00%)
    10.340 USD
    T
    TXMD
    -0.05000
    (-3.42%)
    1.41000 USD
    More
News

Title: Delcath Systems

Sector: Healthcare
Industry: Medical Devices
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.